Blog

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianRetatrutide is an investigational compound that acts on three receptor pathways rather than tirzepatide’s two. Trial…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianMetformin is a diabetes medication that produces modest weight loss for some people; it is not…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianContrave combines naltrexone and bupropion and works on appetite and reward pathways in the brain. GLP-1…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianDifferent drug classes with different mechanisms, different histories and different regulatory positions. Phentermine is a stimulant…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianThese are not competing options so much as different tools with different profiles. Surgery is a…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianRybelsus is semaglutide in tablet form, taken daily. Ozempic is semaglutide injected weekly. Same molecule, very…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianSame molecule, semaglutide, under two brand names for two approved uses at different dose ranges. Ozempic…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianBoth are approved for type 2 diabetes and both are weekly injections. Ozempic is semaglutide, acting…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianTirzepatide acts on two receptor pathways, GLP-1 and GIP. Semaglutide acts on one. That is the…

By Alsen Walker · Editorially reviewed on 25 August 2026 · Not medically reviewed by a clinicianMost comparisons between these medications are made on the wrong basis. People arrive wanting to know…